PTPN22 has been shown to be associated with susceptibility to a number of immune related-diseases, such as type 1 diabetes (T1D), rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) [14]–[16]. Here, PTPN22 is linked to systemic lupus erythematosus.